QA: ABBOTT LABORATORIES in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2021_ABBOTT_LABORATORIES.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000001800, ABBOTT LABORATORIES

  xvar xval
0 AssetsCurrent 20,441,000,000
1 IntangibleAssetsNetIncludingGoodwill 38,528,000,000
2 PropertyPlantAndEquipmentNet 9,029,000,000
3 remainder_Assets 4,550,000,000
4 LiabilitiesCurrent 11,907,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 15,003,000,000
8 SellingGeneralAndAdministrativeExpense 9,696,000,000
9 ResearchAndDevelopmentExpense 2,420,000,000
10 remainder_Expenses 3,175,000,000
11 remainder_Revenues 34,608,000,000
12 remainder_NetIncome 181,000,000
13 remainder_ComprehensiveNetIncome -481,000,000
  yvar yval
0 Assets 72,548,000,000
1 Liabilities 11,907,000,000
2 Expenses 30,294,000,000
3 Revenues 34,608,000,000
4 StockholdersEquity 60,641,000,000
5 NetIncome 4,495,000,000
6 ComprehensiveNetIncome 4,254,500,000
7 BaseVar 75,009,500,000
8 EconomicCapitalRatio 2.57

Edgar->Model Mapping

Feature Distribution

Change over Time